IRIS
BERARDI, Rossana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.552
EU - Europa 9.292
AS - Asia 7.608
SA - Sud America 2.150
AF - Africa 524
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 15
Totale 42.156
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.308
SG - Singapore 2.862
BR - Brasile 1.819
IT - Italia 1.571
CN - Cina 1.554
UA - Ucraina 1.329
RU - Federazione Russa 1.211
DE - Germania 1.110
HK - Hong Kong 1.103
IE - Irlanda 1.068
SE - Svezia 831
VN - Vietnam 638
TR - Turchia 538
FI - Finlandia 534
DK - Danimarca 455
GB - Regno Unito 425
CI - Costa d'Avorio 303
FR - Francia 259
KR - Corea 257
IN - India 230
AR - Argentina 143
CA - Canada 132
PL - Polonia 110
NL - Olanda 100
BD - Bangladesh 85
JP - Giappone 85
MA - Marocco 84
MX - Messico 82
ZA - Sudafrica 75
ID - Indonesia 67
BE - Belgio 63
EC - Ecuador 60
AT - Austria 56
ES - Italia 49
IQ - Iraq 38
CO - Colombia 36
PY - Paraguay 25
RO - Romania 23
PK - Pakistan 21
LT - Lituania 19
UZ - Uzbekistan 19
VE - Venezuela 18
CL - Cile 17
CZ - Repubblica Ceca 17
EG - Egitto 15
PE - Perù 15
TN - Tunisia 15
AZ - Azerbaigian 14
EU - Europa 13
KE - Kenya 13
AE - Emirati Arabi Uniti 11
SA - Arabia Saudita 10
DZ - Algeria 9
KZ - Kazakistan 9
UY - Uruguay 9
AL - Albania 8
AU - Australia 8
NP - Nepal 8
JO - Giordania 7
NZ - Nuova Zelanda 7
HN - Honduras 6
IL - Israele 6
PS - Palestinian Territory 6
BG - Bulgaria 5
BO - Bolivia 5
BY - Bielorussia 5
CH - Svizzera 5
GR - Grecia 5
KG - Kirghizistan 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
HR - Croazia 4
JM - Giamaica 4
BH - Bahrain 3
BI - Burundi 3
IR - Iran 3
LB - Libano 3
MY - Malesia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BW - Botswana 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
PH - Filippine 2
PT - Portogallo 2
SM - San Marino 2
Totale 42.130
Salva come PNG Salva come JPEG
Città #
Dallas 2.542
Ashburn 2.410
Chandler 2.048
Singapore 1.778
Jacksonville 1.505
Fairfield 1.487
Des Moines 1.176
Hong Kong 1.098
Dublin 1.061
Boardman 985
Wilmington 731
Woodbridge 660
Seattle 645
New York 628
Houston 602
Ann Arbor 494
Cambridge 480
Los Angeles 392
Beijing 389
Lawrence 388
Princeton 388
Munich 367
San Mateo 364
Abidjan 303
The Dalles 267
Moscow 244
Ho Chi Minh City 236
Hefei 229
Centro 216
San Diego 184
São Paulo 165
Helsinki 162
Buffalo 156
Chicago 141
Hanoi 141
Turku 137
London 120
Turin 114
Ancona 108
Santa Clara 103
Washington 101
Pune 100
Warsaw 97
Rome 94
Tokyo 71
Guangzhou 69
Milan 66
Brussels 62
Rio de Janeiro 62
Montreal 60
Shanghai 57
Atlanta 51
Nuremberg 51
Brooklyn 49
Columbus 48
Johannesburg 48
Denver 47
Chennai 45
Marche 41
Poplar 41
Stockholm 41
Belo Horizonte 40
Falls Church 40
Norwalk 37
Phoenix 37
Orem 35
Salt Lake City 35
Boston 34
Haiphong 33
Brasília 32
Elk Grove Village 31
Urbisaglia 31
Wuhan 31
Mexico City 30
San Francisco 28
Curitiba 27
Tolentino 27
Kilburn 26
Biên Hòa 24
Vienna 24
Amsterdam 23
Quito 23
Salvador 23
Secaucus 23
Porto Alegre 22
Zhengzhou 22
Manchester 21
Prescot 21
Redmond 21
Tampa 21
Frankfurt am Main 20
Guarulhos 20
Jiaxing 20
Naples 20
Ankara 19
Porto 19
Da Nang 18
Baghdad 17
Charlotte 17
Dhaka 17
Totale 27.954
Salva come PNG Salva come JPEG
Nome #
[11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas 1.609
The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer 253
A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy 244
Anemia may influence the outcome of patients undergoing neoadjuvant treatment for rectal cancer 200
Endometriosis-associated Clear Cell Carcinoma of the Abdominal Wall After Caesarean Section: A Case Report and Review of the Literature 194
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis 180
Are liver nested stromal epithelial tumors always low aggressive? 178
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 168
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 161
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy 159
Syndrome of inappropriate antidiuretic hormone secretion (Siadh): Optimal management 159
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases 158
1621P miRNA signature as early predictor of hyponatremia and survival in lung cancer: Preliminary results from the ISA retrospective study 158
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 157
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 157
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma. 154
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 153
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 153
Adjuvant treatment with Capecitabine in patients who received orthotopic liver transplantation with incidental diagnosis of intrahepatic cholangiocarcinoma. Implications on DPYD polymorphisms assessment: report of two cases and review of the literature 152
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 152
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 150
Optimal management of resected gastric cancer 150
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. 148
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. 147
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 147
The role of an immune checkpoint score in resected non-small cell lung cancer patients' prognosis 147
Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO) 147
Metabolic phenotype of bladder cancer 147
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 146
The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients. 144
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 144
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 143
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry 142
Squamous cell carcinoma of the lung: clinical criteria for treatment strategy 141
85P NSCLC-Pro ClustAI: A machine learning model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 140
Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy. 139
A cost-benefit analysis of chemotherapy for gastric cancer. 139
Long‑responders to anti‑HER2 therapies: A case report and review of the literature 139
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going? 138
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 138
Contrasting Digital Fake News in Health: an Interdisciplinary Approach 138
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 137
5-Fluorouracil pharmacogenomics: still rocking after all these years? 136
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 135
Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study 135
Role of DCE-MR in predicting breast cancer subtypes. 133
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic 132
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 131
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 131
Adjuvant treatment after surgical resection 131
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 129
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy. 128
Managing hyponatremia in lung cancer: latest evidence and clinical implications 128
Modifications of taste sensitivity in cancer patients: a method for the evaluations of dysgeusia 128
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study 128
The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions 128
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 126
Seminoma Retroperitoneal Relapse 23 Years After Surgery 126
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 126
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival 125
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 125
Gender Differences and Outcomes in Melanoma Patients 124
Medical treatment for cholangiocarcinoma 124
Contrasting Fake News in Oncology: The First Declaration of Good Communication 124
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer 124
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials 124
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 123
Severe prognosis of signet-ring cell adenocarcinoma occurring in meckel’s diverticulum 121
Electrolyte disorders in cancer patients: a systematic review 121
Thymic Malignancies in the targeted terapies era 120
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 120
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 120
Chromium Exposure and Germinal Embryonal Carcinoma: first Two Cases and Review of the Literature 119
Rossana Berardi, Mariangela Torniai, Agnese Savini, Silvia Rinaldi, Stefano Cascinu. Gastro-entero-pancreatic neuroendocrine tumors: is now time for a new approach? 119
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. 118
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 118
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 117
Gender differences and outcome of melanoma patients 117
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 117
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review 117
High CTLA-4 expression correlates with poor prognosis in thymoma patients 117
Benefits and limitations of a multidisciplinary approach in cancer patient management 117
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 116
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 116
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 116
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment 115
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study 115
High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients 115
New target therapies in advanced pancreatic cancer. 114
Novel perspectives for the treatment of gastric cancer: From a global approach to a personalized strategy 114
Hyponatremia in cancer patients: Time for a new approach 114
Systemic treatment for lung carcinoids: from bench to bedside 114
Progress of molecular targeted therapies for advanced renal cell carcinoma. 114
Lynphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients. 113
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data 112
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis 112
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 112
Correlation between apparent diffusion coefficient of magnetic resonance imaging and tumor-infiltrating lymphocytes in breast cancer 112
Adenocarcinoma arising from ileoanal J- Pouch mucosa: An announced event? 111
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 110
Totale 15.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 218.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 218.977
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.183 0 0 0 0 0 391 505 435 489 452 568 343
2021/20223.052 169 639 78 98 42 224 124 209 303 207 328 631
2022/20236.355 518 648 404 531 338 1.618 2 325 1.357 58 411 145
2023/20243.659 580 83 234 408 574 877 52 132 10 131 51 527
2024/20258.278 851 754 371 158 339 357 692 323 1.948 658 824 1.003
2025/202611.384 1.508 1.944 2.531 2.583 2.424 394 0 0 0 0 0 0
Totale 43.178